HUP0303344A2 - Karbamátszármazékok alkalmazása mozgászavarok megelőzésére és kezelésére - Google Patents
Karbamátszármazékok alkalmazása mozgászavarok megelőzésére és kezeléséreInfo
- Publication number
- HUP0303344A2 HUP0303344A2 HU0303344A HUP0303344A HUP0303344A2 HU P0303344 A2 HUP0303344 A2 HU P0303344A2 HU 0303344 A HU0303344 A HU 0303344A HU P0303344 A HUP0303344 A HU P0303344A HU P0303344 A2 HUP0303344 A2 HU P0303344A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- movement disorders
- phenyl
- carbon
- preventing
- Prior art date
Links
- 208000016285 Movement disease Diseases 0.000 title abstract 3
- 150000004657 carbamic acid derivatives Chemical class 0.000 title 1
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- AKZWRTCWNXHHFR-PDIZUQLASA-N [(3S)-oxolan-3-yl] N-[(2S,3S)-4-[(5S)-5-benzyl-3-[(2R)-2-carbamoyloxy-2,3-dihydro-1H-inden-1-yl]-4-oxo-3H-pyrrol-5-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate Chemical compound NC(=O)O[C@@H]1Cc2ccccc2C1C1C=N[C@](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CCOC2)(Cc2ccccc2)C1=O AKZWRTCWNXHHFR-PDIZUQLASA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- BQYRVMAWJCIIKI-UHFFFAOYSA-N carbamic acid;1-phenylethane-1,2-diol Chemical class NC(O)=O.OCC(O)C1=CC=CC=C1 BQYRVMAWJCIIKI-UHFFFAOYSA-N 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány tárgyát halogénezett 2-fenil-1,2-etándiol-monokarbamátokvagy -dikarbamátok alkalmazásán alapuló, mozgászavarok megelőzésére éskezelésére szolgáló eljárás képezi. A találmány szerinti eljárássalúgy előznek meg vagy kezelnek mozgászavarokat, hogy gyógykezeléshezhatásos mennyiségben gyógyászati beavatkozásra szoruló alanyokszervezetébe juttatnak olyan karbamátszármazékot, amelynek (I) vagy(II) általános képletében - a fenilgyűrűhöz kapcsolódó X jelentése 1-5halogénatom, mégpedig fluoratom, klóratom, brómatom vagy jódatom; -R1, R2, R3, R4, R5 és R6 jelentése pedig - egymástól függetlenül -hidrogénatom vagy 1-4 szénatomos alkilcsoport, amely adott esetbenhelyettesítve lehet olyan fenilcsoporttal, amely adott esetben maga ishelyettesítve lehet egymástól független szubsztituensekkel, mégpedigegy vagy több halogénatommal, 1-4 szénatomos alkilcsoporttal, 1-4szénatomos alkoxicsoporttal, aminocsoporttal, nitrocsoporttal és/vagycianocsoporttal. Ó
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27168301P | 2001-02-27 | 2001-02-27 | |
PCT/US2002/005542 WO2002067926A1 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating movement disorders |
US10/081,501 US6589985B2 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating movement disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0303344A2 true HUP0303344A2 (hu) | 2004-01-28 |
HUP0303344A3 HUP0303344A3 (en) | 2012-07-30 |
Family
ID=26765643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0303344A HUP0303344A3 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing and treating movement disorders |
Country Status (28)
Country | Link |
---|---|
US (1) | US6589985B2 (hu) |
EP (1) | EP1411917B1 (hu) |
JP (1) | JP2004527492A (hu) |
KR (1) | KR100858232B1 (hu) |
CN (1) | CN1262272C (hu) |
AR (1) | AR033426A1 (hu) |
AT (1) | ATE369130T1 (hu) |
AU (1) | AU2002247204B2 (hu) |
BR (1) | BR0207831A (hu) |
CA (1) | CA2439478C (hu) |
CY (1) | CY1106924T1 (hu) |
CZ (1) | CZ20032299A3 (hu) |
DE (1) | DE60221670T2 (hu) |
DK (1) | DK1411917T3 (hu) |
ES (1) | ES2291454T3 (hu) |
HK (1) | HK1067305A1 (hu) |
HU (1) | HUP0303344A3 (hu) |
IL (2) | IL157592A0 (hu) |
MX (1) | MXPA03007719A (hu) |
MY (1) | MY157373A (hu) |
NO (1) | NO20033803L (hu) |
NZ (1) | NZ551954A (hu) |
PL (1) | PL364679A1 (hu) |
PT (1) | PT1411917E (hu) |
RS (1) | RS50676B (hu) |
RU (1) | RU2294739C2 (hu) |
TW (1) | TWI331524B (hu) |
WO (1) | WO2002067926A1 (hu) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002007822A2 (en) * | 2000-07-21 | 2002-01-31 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
CA2439295C (en) * | 2001-02-27 | 2010-05-25 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neurodegenerative disorders |
KR20040016994A (ko) | 2001-07-16 | 2004-02-25 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 신경병증 통증 및 군발성 및 편두통성 두통-관련 통증의예방 또는 치료를 위해 사용하기 위한 카바메이트 화합물 |
PL1890684T3 (pl) | 2005-06-08 | 2014-05-30 | Sk Biopharmaceuticals Co Ltd | Leczenie zaburzeń snu i czuwania |
PE20070325A1 (es) * | 2005-06-29 | 2007-05-12 | Alza Corp | Formas de dosificacion oral que comprenden compuestos derivados de carbamato |
WO2007018496A1 (en) * | 2005-07-26 | 2007-02-15 | Janssen Pharmaceutica, N.V. | Methods for treating substance-related disorders |
CN101568333A (zh) * | 2006-10-31 | 2009-10-28 | 詹森药业有限公司 | 广泛性发育障碍的治疗 |
CN102781436B (zh) | 2009-11-06 | 2014-01-08 | 爱思开生物制药株式会社 | 纤维肌痛综合征的治疗方法 |
RU2556585C2 (ru) | 2009-11-06 | 2015-07-10 | Ск Биофармасъютиклс Ко., Лтд. | Способы лечения синдрома дефицита внимания и гиперактивности |
US8623913B2 (en) * | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
US9907776B2 (en) | 2013-03-12 | 2018-03-06 | Bio-Pharm Solutions, Co., Ltd. | Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same |
EP2968210A4 (en) * | 2013-03-12 | 2016-12-28 | Bio-Pharm Solutions Co Ltd | PHENYL ACARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING PEDIATRIC EPILEPSY AND EPILEPSY-MEDIATED SYNDROME |
BR112018067663B1 (pt) | 2016-02-29 | 2023-01-10 | Bio-Pharm Solutions Co., Ltd | Compostos derivados de sulfamato, seus usos e composição farmacêutica |
US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
MX2019006941A (es) * | 2016-12-14 | 2019-09-06 | Sk Biopharmaceuticals Co Ltd | Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor. |
WO2018222954A1 (en) | 2017-06-02 | 2018-12-06 | Jazz Pharmaceuticals International Iii Limited | Methods and compositions for treating excessive sleepiness |
US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3313692A (en) | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
US3265728A (en) | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
US5698588A (en) | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
-
2002
- 2002-02-21 CN CNB028089243A patent/CN1262272C/zh not_active Expired - Fee Related
- 2002-02-21 US US10/081,501 patent/US6589985B2/en not_active Expired - Fee Related
- 2002-02-21 HU HU0303344A patent/HUP0303344A3/hu unknown
- 2002-02-21 DE DE60221670T patent/DE60221670T2/de not_active Expired - Lifetime
- 2002-02-21 AT AT02714978T patent/ATE369130T1/de active
- 2002-02-21 AU AU2002247204A patent/AU2002247204B2/en not_active Ceased
- 2002-02-21 JP JP2002567293A patent/JP2004527492A/ja active Pending
- 2002-02-21 KR KR1020037011271A patent/KR100858232B1/ko not_active IP Right Cessation
- 2002-02-21 RS YUP-677/03A patent/RS50676B/sr unknown
- 2002-02-21 CZ CZ20032299A patent/CZ20032299A3/cs unknown
- 2002-02-21 NZ NZ551954A patent/NZ551954A/en unknown
- 2002-02-21 PL PL02364679A patent/PL364679A1/xx not_active Application Discontinuation
- 2002-02-21 CA CA2439478A patent/CA2439478C/en not_active Expired - Fee Related
- 2002-02-21 WO PCT/US2002/005542 patent/WO2002067926A1/en active IP Right Grant
- 2002-02-21 BR BR0207831-7A patent/BR0207831A/pt not_active Application Discontinuation
- 2002-02-21 RU RU2003128985/14A patent/RU2294739C2/ru not_active IP Right Cessation
- 2002-02-21 EP EP02714978A patent/EP1411917B1/en not_active Expired - Lifetime
- 2002-02-21 MX MXPA03007719A patent/MXPA03007719A/es active IP Right Grant
- 2002-02-21 IL IL15759202A patent/IL157592A0/xx unknown
- 2002-02-21 DK DK02714978T patent/DK1411917T3/da active
- 2002-02-21 PT PT02714978T patent/PT1411917E/pt unknown
- 2002-02-21 ES ES02714978T patent/ES2291454T3/es not_active Expired - Lifetime
- 2002-02-27 TW TW091103503A patent/TWI331524B/zh not_active IP Right Cessation
- 2002-02-27 AR ARP020100698A patent/AR033426A1/es unknown
- 2002-02-27 MY MYPI20020692A patent/MY157373A/en unknown
-
2003
- 2003-08-26 NO NO20033803A patent/NO20033803L/no not_active Application Discontinuation
- 2003-08-26 IL IL157592A patent/IL157592A/en not_active IP Right Cessation
-
2004
- 2004-10-28 HK HK04108466A patent/HK1067305A1/xx not_active IP Right Cessation
-
2007
- 2007-10-10 CY CY20071101301T patent/CY1106924T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0303344A2 (hu) | Karbamátszármazékok alkalmazása mozgászavarok megelőzésére és kezelésére | |
HUP0303264A2 (hu) | Karbamátszármazékok alkalmazása idegrendszeri elfajulással járó rendellenességek megelőzésére és kezelésére | |
HUP0303243A2 (hu) | Karbamátszármazékok alkalmazása bipoláris rendellenesség megelőzésére és kezelésére | |
HUP0303261A2 (hu) | Karbamátszármazékok alkalmazása bipoláris rendellenesség megelőzésére és kezelésére | |
BRPI0515374A (pt) | métodos de tratamento de epileptogenêse e epilepsia | |
HUP0303236A2 (hu) | Karbamátszármazékok alkalmazása fájdalomcsillapításra | |
HUP0303262A2 (hu) | Karbamátszármazékok alkalmazása szorongásos rendellenességek megelőzésére és kezelésére | |
HUP0303342A2 (hu) | Karbamátszármazékok alkalmazása elmezavarok megelőzésére és kezelésére | |
PT1305082E (pt) | Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca | |
HUP0401367A2 (hu) | Karbamátvegyületek alkalmazása neuropátiás fájdalom, valamint cluster és migrénes fejfájással társuló fájdalom megelőzésére vagy kezelésére | |
HUP0401110A2 (hu) | Karbamátvegyületek alkalmazása neuropátiás fájdalom, valamint cluster és migrénes fejfájással társuló fájdalom megelőzésére vagy kezelésére | |
MY149385A (en) | Methods for treating substance-related disorders | |
MY136347A (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |